Rankings
▼
Calendar
PEPG Q1 2024 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena
PEPG
PepGen Inc.
$435M
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$376,000
Operating Income
-$20M
Net Income
-$18M
EPS (Diluted)
$-0.63
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$23M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$207M
Total Liabilities
$28M
Stockholders' Equity
$179M
Cash & Equivalents
$134M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$376,000
$0
—
Operating Income
-$20M
-$18M
-9.8%
Net Income
-$18M
-$16M
-10.4%
← FY 2024
All Quarters
Q2 2024 →